Annals of the New York Academy of Sciences

© The New York Academy of Sciences

Cover image for Vol. 1187 Addiction Reviews 2

February 2010

Volume 1187 Addiction Reviews 2

Pages 1–402

  1. Introduction

    1. Top of page
    2. Introduction
    3. Preface
    4. Part I. Medications for addiction and relevant neurotransmitter systems
    5. Part II. Drug and HIV toxicities
    6. Part III. Physiology
    7. Part IV. Imaging
    8. Part V. Development
    9. Part VI. Genetics
    10. Part VII. Behavioral mechanisms
    11. Part VIII. Comorbidity
    12. Part IX. Nonsubstance addictions
    13. Part X. Molecules for addiction
    14. Part XI. Epidemiology
    15. Part XII. Places and institutions
    1. Introduction to Addiction Reviews 2 (pages 1–2)

      George R. Uhl, for the Editorial Advisory Board

      Article first published online: 18 FEB 2010 | DOI: 10.1111/j.1749-6632.2009.05418.x

  2. Preface

    1. Top of page
    2. Introduction
    3. Preface
    4. Part I. Medications for addiction and relevant neurotransmitter systems
    5. Part II. Drug and HIV toxicities
    6. Part III. Physiology
    7. Part IV. Imaging
    8. Part V. Development
    9. Part VI. Genetics
    10. Part VII. Behavioral mechanisms
    11. Part VIII. Comorbidity
    12. Part IX. Nonsubstance addictions
    13. Part X. Molecules for addiction
    14. Part XI. Epidemiology
    15. Part XII. Places and institutions
    1. Preface to Addiction Reviews 2 (page 3)

      George F. Koob

      Article first published online: 18 FEB 2010 | DOI: 10.1111/j.1749-6632.2009.05431.x

  3. Part I. Medications for addiction and relevant neurotransmitter systems

    1. Top of page
    2. Introduction
    3. Preface
    4. Part I. Medications for addiction and relevant neurotransmitter systems
    5. Part II. Drug and HIV toxicities
    6. Part III. Physiology
    7. Part IV. Imaging
    8. Part V. Development
    9. Part VI. Genetics
    10. Part VII. Behavioral mechanisms
    11. Part VIII. Comorbidity
    12. Part IX. Nonsubstance addictions
    13. Part X. Molecules for addiction
    14. Part XI. Epidemiology
    15. Part XII. Places and institutions
    1. Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders (pages 4–34)

      Christian A. Heidbreder and Amy H. Newman

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05149.x

    2. Cocaine-induced neuroadaptations in glutamate transmission : Potential therapeutic targets for craving and addiction (pages 35–75)

      Heath D. Schmidt and R. Christopher Pierce

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05144.x

    3. Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies (pages 76–100)

      David V. Herin, Craig. R. Rush and John Grabowski

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05145.x

  4. Part II. Drug and HIV toxicities

    1. Top of page
    2. Introduction
    3. Preface
    4. Part I. Medications for addiction and relevant neurotransmitter systems
    5. Part II. Drug and HIV toxicities
    6. Part III. Physiology
    7. Part IV. Imaging
    8. Part V. Development
    9. Part VI. Genetics
    10. Part VII. Behavioral mechanisms
    11. Part VIII. Comorbidity
    12. Part IX. Nonsubstance addictions
    13. Part X. Molecules for addiction
    14. Part XI. Epidemiology
    15. Part XII. Places and institutions
    1. Amphetamine toxicities : Classical and emerging mechanisms (pages 101–121)

      Bryan K. Yamamoto, Anna Moszczynska and Gary A. Gudelsky

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05141.x

    2. Human immunodeficiency virus–associated neurocognitive disorder : Pathophysiology in relation to drug addiction (pages 122–128)

      Avindra Nath

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05277.x

  5. Part III. Physiology

    1. Top of page
    2. Introduction
    3. Preface
    4. Part I. Medications for addiction and relevant neurotransmitter systems
    5. Part II. Drug and HIV toxicities
    6. Part III. Physiology
    7. Part IV. Imaging
    8. Part V. Development
    9. Part VI. Genetics
    10. Part VII. Behavioral mechanisms
    11. Part VIII. Comorbidity
    12. Part IX. Nonsubstance addictions
    13. Part X. Molecules for addiction
    14. Part XI. Epidemiology
    15. Part XII. Places and institutions
    1. Synaptic plasticity in the mesolimbic system : Therapeutic implications for substance abuse (pages 129–139)

      Billy T. Chen, F. Woodward Hopf and Antonello Bonci

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05154.x

    2. Electrophysiological correlates of abused drugs : Relation to natural rewards (pages 140–147)

      Sam A. Deadwyler

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05155.x

  6. Part IV. Imaging

    1. Top of page
    2. Introduction
    3. Preface
    4. Part I. Medications for addiction and relevant neurotransmitter systems
    5. Part II. Drug and HIV toxicities
    6. Part III. Physiology
    7. Part IV. Imaging
    8. Part V. Development
    9. Part VI. Genetics
    10. Part VII. Behavioral mechanisms
    11. Part VIII. Comorbidity
    12. Part IX. Nonsubstance addictions
    13. Part X. Molecules for addiction
    14. Part XI. Epidemiology
    15. Part XII. Places and institutions
    1. Neurochemistry of drug action : Insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction (pages 148–171)

      Stephanie C. Licata and Perry F. Renshaw

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05143.x

  7. Part V. Development

    1. Top of page
    2. Introduction
    3. Preface
    4. Part I. Medications for addiction and relevant neurotransmitter systems
    5. Part II. Drug and HIV toxicities
    6. Part III. Physiology
    7. Part IV. Imaging
    8. Part V. Development
    9. Part VI. Genetics
    10. Part VII. Behavioral mechanisms
    11. Part VIII. Comorbidity
    12. Part IX. Nonsubstance addictions
    13. Part X. Molecules for addiction
    14. Part XI. Epidemiology
    15. Part XII. Places and institutions
    1. Cocaine addiction in mothers : Potential effects on maternal care and infant development (pages 172–183)

      Lane Strathearn and Linda C. Mayes

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05142.x

  8. Part VI. Genetics

    1. Top of page
    2. Introduction
    3. Preface
    4. Part I. Medications for addiction and relevant neurotransmitter systems
    5. Part II. Drug and HIV toxicities
    6. Part III. Physiology
    7. Part IV. Imaging
    8. Part V. Development
    9. Part VI. Genetics
    10. Part VII. Behavioral mechanisms
    11. Part VIII. Comorbidity
    12. Part IX. Nonsubstance addictions
    13. Part X. Molecules for addiction
    14. Part XI. Epidemiology
    15. Part XII. Places and institutions
    1. Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment (pages 184–207)

      Vadim Yuferov, Orna Levran, Dmitri Proudnikov, David A. Nielsen and Mary Jeanne Kreek

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05275.x

    2. Addictions and their familiality in Iceland (pages 208–217)

      Thorarinn Tyrfingsson, Thorgeir E. Thorgeirsson, Frank Geller, Valgerdur Runarsdóttir, Ingunn Hansdóttir, Gyda Bjornsdottir, Anna K. Wiste, Gudrun A. Jonsdottir, Hreinn Stefansson, Jeffrey R. Gulcher, Hogni Oskarsson, Daniel Gudbjartsson and Kari Stefansson

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05151.x

    3. Transgenic mice in the study of drug addiction and the effects of psychostimulant drugs (pages 218–246)

      Ichiro Sora, BingJin Li, Moe Igari, F. Scott Hall and Kazutaka Ikeda

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05276.x

  9. Part VII. Behavioral mechanisms

    1. Top of page
    2. Introduction
    3. Preface
    4. Part I. Medications for addiction and relevant neurotransmitter systems
    5. Part II. Drug and HIV toxicities
    6. Part III. Physiology
    7. Part IV. Imaging
    8. Part V. Development
    9. Part VI. Genetics
    10. Part VII. Behavioral mechanisms
    11. Part VIII. Comorbidity
    12. Part IX. Nonsubstance addictions
    13. Part X. Molecules for addiction
    14. Part XI. Epidemiology
    15. Part XII. Places and institutions
    1. Conditioned taste aversion learning : Implications for animal models of drug abuse (pages 247–275)

      Catherine M. Davis and Anthony L. Riley

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05147.x

  10. Part VIII. Comorbidity

    1. Top of page
    2. Introduction
    3. Preface
    4. Part I. Medications for addiction and relevant neurotransmitter systems
    5. Part II. Drug and HIV toxicities
    6. Part III. Physiology
    7. Part IV. Imaging
    8. Part V. Development
    9. Part VI. Genetics
    10. Part VII. Behavioral mechanisms
    11. Part VIII. Comorbidity
    12. Part IX. Nonsubstance addictions
    13. Part X. Molecules for addiction
    14. Part XI. Epidemiology
    15. Part XII. Places and institutions
    1. The strong relationship between bipolar and substance-use disorder : Mechanisms and treatment implications (pages 276–293)

      Alan C. Swann

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05146.x

  11. Part IX. Nonsubstance addictions

    1. Top of page
    2. Introduction
    3. Preface
    4. Part I. Medications for addiction and relevant neurotransmitter systems
    5. Part II. Drug and HIV toxicities
    6. Part III. Physiology
    7. Part IV. Imaging
    8. Part V. Development
    9. Part VI. Genetics
    10. Part VII. Behavioral mechanisms
    11. Part VIII. Comorbidity
    12. Part IX. Nonsubstance addictions
    13. Part X. Molecules for addiction
    14. Part XI. Epidemiology
    15. Part XII. Places and institutions
    1. Shared brain vulnerabilities open the way for nonsubstance addictions: Carving addiction at a new joint? (pages 294–315)

      Joseph Frascella, Marc N. Potenza, Lucy L. Brown and Anna Rose Childress

      Article first published online: 29 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05420.x

  12. Part X. Molecules for addiction

    1. Top of page
    2. Introduction
    3. Preface
    4. Part I. Medications for addiction and relevant neurotransmitter systems
    5. Part II. Drug and HIV toxicities
    6. Part III. Physiology
    7. Part IV. Imaging
    8. Part V. Development
    9. Part VI. Genetics
    10. Part VII. Behavioral mechanisms
    11. Part VIII. Comorbidity
    12. Part IX. Nonsubstance addictions
    13. Part X. Molecules for addiction
    14. Part XI. Epidemiology
    15. Part XII. Places and institutions
    1. Regulation of the dopamine transporter : Aspects relevant to psychostimulant drugs of abuse (pages 316–340)

      Kyle C. Schmitt and Maarten E. A. Reith

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05148.x

    2. Regulator of G protein–signaling proteins and addictive drugs (pages 341–352)

      John Traynor

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05150.x

  13. Part XI. Epidemiology

    1. Top of page
    2. Introduction
    3. Preface
    4. Part I. Medications for addiction and relevant neurotransmitter systems
    5. Part II. Drug and HIV toxicities
    6. Part III. Physiology
    7. Part IV. Imaging
    8. Part V. Development
    9. Part VI. Genetics
    10. Part VII. Behavioral mechanisms
    11. Part VIII. Comorbidity
    12. Part IX. Nonsubstance addictions
    13. Part X. Molecules for addiction
    14. Part XI. Epidemiology
    15. Part XII. Places and institutions
    1. Novel phenotype issues raised in cross-national epidemiological research on drug dependence (pages 353–369)

      James C. (Jim) Anthony

      Article first published online: 29 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05419.x

  14. Part XII. Places and institutions

    1. Top of page
    2. Introduction
    3. Preface
    4. Part I. Medications for addiction and relevant neurotransmitter systems
    5. Part II. Drug and HIV toxicities
    6. Part III. Physiology
    7. Part IV. Imaging
    8. Part V. Development
    9. Part VI. Genetics
    10. Part VII. Behavioral mechanisms
    11. Part VIII. Comorbidity
    12. Part IX. Nonsubstance addictions
    13. Part X. Molecules for addiction
    14. Part XI. Epidemiology
    15. Part XII. Places and institutions
    1. Office of National Drug Control Policy : A scientist in drug policy in Washington, DC (pages 370–402)

      Bertha K. Madras

      Article first published online: 8 JAN 2010 | DOI: 10.1111/j.1749-6632.2009.05278.x

SEARCH

SEARCH BY CITATION